FG Nexus (FGNX)
Market Price (6/20/2026): $5.53 | Market Cap: $36.7 MilSector: Financials | Industry: Asset Management & Custody Banks
FG Nexus (FGNX)
Market Price (6/20/2026): $5.53Market Cap: $36.7 MilSector: FinancialsIndustry: Asset Management & Custody Banks
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -78% Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 97% | Weak multi-year price returns2Y Excs Rtn is -134%, 3Y Excs Rtn is -169% | Weak revenue growthRev Chg QQuarterly Revenue Change % is 0.0% Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 69% Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -85%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -85% Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 93% Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -258% High stock price volatilityVol 12M is 157% Key risksFGNX key risks include [1] its heavy strategic reliance on volatile Ethereum holdings, Show more. |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -78% |
| Strong revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is 97% |
| Weak multi-year price returns2Y Excs Rtn is -134%, 3Y Excs Rtn is -169% |
| Weak revenue growthRev Chg QQuarterly Revenue Change % is 0.0% |
| Significant share based compensationSBC/Rev LTMShare Based Compensation / Revenue (Sales), Last Twelve Months (LTM) is 69% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -85%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -85% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 93% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -258% |
| High stock price volatilityVol 12M is 157% |
| Key risksFGNX key risks include [1] its heavy strategic reliance on volatile Ethereum holdings, Show more. |
Qualitative Assessment
AI Analysis | Feedback
FG Nexus (FGNX) stock has lost about 15% since 2/28/2026 because of the following key factors:
1. Significant Earnings Miss in Fiscal Q1 2026.
FG Nexus (FGNX) reported an earnings per share (EPS) miss of -$5.41 for fiscal Q1 2026, which concluded on March 30, 2026. This substantial underperformance in its quarterly financial results likely contributed to negative investor sentiment and the stock's decline during the period.
2. Negative Investor Sentiment Following Reverse Stock Split.
The company executed a 1-for-5 reverse stock split on February 13, 2026, immediately preceding the specified period. While intended to increase share price, such corporate actions often signal underlying financial challenges and can lead to a sustained negative market perception, contributing to downward pressure on the stock.
Show more
FG Nexus (FGNX) stock has lost about 15% since 2/28/2026 because of the following key factors:
1. Significant Earnings Miss in Fiscal Q1 2026.
FG Nexus (FGNX) reported an earnings per share (EPS) miss of -$5.41 for fiscal Q1 2026, which concluded on March 30, 2026. This substantial underperformance in its quarterly financial results likely contributed to negative investor sentiment and the stock's decline during the period.
2. Negative Investor Sentiment Following Reverse Stock Split.
The company executed a 1-for-5 reverse stock split on February 13, 2026, immediately preceding the specified period. While intended to increase share price, such corporate actions often signal underlying financial challenges and can lead to a sustained negative market perception, contributing to downward pressure on the stock.
3. Underperformance of Digital Asset Holdings.
FG Nexus operates a digital asset treasury primarily focused on Ethereum (ETH) and tokenization opportunities. The company's reported fiscal Q1 2026 earnings miss, reflecting financial performance during the period, suggests an underperformance or significant volatility in its digital asset holdings, which form a major part of its business model.
Show less
Stock Movement Drivers
Fundamental Drivers
The -15.5% change in FGNX stock from 2/28/2026 to 6/19/2026 was primarily driven by a -92.9% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 2282026 | 6192026 | Change |
|---|---|---|---|
| Stock Price ($) | 6.71 | 5.67 | -15.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 10 | 11 | 8.7% |
| P/S Multiple | 0.3 | 3.4 | 1000.8% |
| Shares Outstanding (Mil) | 0 | 7 | -92.9% |
| Cumulative Contribution | -15.5% |
Market Drivers
2/28/2026 to 6/19/2026| Return | Correlation | |
|---|---|---|
| FGNX | -15.5% | |
| Market (SPY) | 9.2% | 63.9% |
| Sector (XLF) | 4.7% | 46.9% |
Fundamental Drivers
The -64.3% change in FGNX stock from 11/30/2025 to 6/19/2026 was primarily driven by a -92.9% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 11302025 | 6192026 | Change |
|---|---|---|---|
| Stock Price ($) | 15.90 | 5.67 | -64.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 10 | 11 | 8.7% |
| P/S Multiple | 0.7 | 3.4 | 364.6% |
| Shares Outstanding (Mil) | 0 | 7 | -92.9% |
| Cumulative Contribution | -64.3% |
Market Drivers
11/30/2025 to 6/19/2026| Return | Correlation | |
|---|---|---|
| FGNX | -64.3% | |
| Market (SPY) | 9.9% | 56.2% |
| Sector (XLF) | 1.3% | 36.1% |
Fundamental Drivers
The -93.1% change in FGNX stock from 5/31/2025 to 6/19/2026 was primarily driven by a -96.2% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 5312025 | 6192026 | Change |
|---|---|---|---|
| Stock Price ($) | 82.25 | 5.67 | -93.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 6 | 11 | 97.3% |
| P/S Multiple | 3.7 | 3.4 | -8.8% |
| Shares Outstanding (Mil) | 0 | 7 | -96.2% |
| Cumulative Contribution | -93.1% |
Market Drivers
5/31/2025 to 6/19/2026| Return | Correlation | |
|---|---|---|
| FGNX | -93.1% | |
| Market (SPY) | 28.1% | 17.4% |
| Sector (XLF) | 6.7% | 11.4% |
Fundamental Drivers
The -97.4% change in FGNX stock from 5/31/2023 to 6/19/2026 was primarily driven by a -98.9% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 5312023 | 6192026 | Change |
|---|---|---|---|
| Stock Price ($) | 221.25 | 5.67 | -97.4% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 17 | 11 | -34.0% |
| P/S Multiple | 1.0 | 3.4 | 241.6% |
| Shares Outstanding (Mil) | 0 | 7 | -98.9% |
| Cumulative Contribution | -97.4% |
Market Drivers
5/31/2023 to 6/19/2026| Return | Correlation | |
|---|---|---|
| FGNX | -97.4% | |
| Market (SPY) | 85.7% | 9.7% |
| Sector (XLF) | 77.0% | 8.8% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| FGNX Return | -11% | -24% | -44% | -45% | -87% | -57% | -99% |
| Peers Return | 9% | -18% | 16% | 2% | 8% | -17% | -4% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 8% | 98% |
Monthly Win Rates [3] | |||||||
| FGNX Win Rate | 50% | 58% | 25% | 33% | 8% | 50% | |
| Peers Win Rate | 47% | 31% | 61% | 47% | 50% | 30% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 50% | |
Max Drawdowns [4] | |||||||
| FGNX Max Drawdown | -67% | -64% | -62% | -62% | -94% | -75% | |
| Peers Max Drawdown | -27% | -38% | -24% | -17% | -26% | -26% | |
| S&P 500 Max Drawdown | -5% | -25% | -10% | -8% | -19% | -9% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: VRTS, SLRC, GEG, ALP, AVAT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 6/18/2026 (YTD)
How Low Can It Go
| Event | FGNX | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -26.2% | -18.8% |
| % Gain to Breakeven | 35.5% | 23.1% |
| Time to Breakeven | 96 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -22.7% | -9.5% |
| % Gain to Breakeven | 29.3% | 10.5% |
| Time to Breakeven | 7 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -21.1% | -33.7% |
| % Gain to Breakeven | 26.8% | 50.9% |
| Time to Breakeven | 338 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -42.6% | -19.2% |
| % Gain to Breakeven | 74.3% | 23.8% |
| Time to Breakeven | 848 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -29.9% | -12.2% |
| % Gain to Breakeven | 42.6% | 13.9% |
| Time to Breakeven | 204 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -26.3% | -6.8% |
| % Gain to Breakeven | 35.6% | 7.3% |
| Time to Breakeven | 1939 days | 15 days |
In The Past
FG Nexus's stock fell -26.2% during the 2025 US Tariff Shock. Such a loss loss requires a 35.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
| Event | FGNX | S&P 500 |
|---|---|---|
| 2025 US Tariff Shock | ||
| % Loss | -26.2% | -18.8% |
| % Gain to Breakeven | 35.5% | 23.1% |
| Time to Breakeven | 96 days | 79 days |
| Summer-Fall 2023 Five Percent Yield Shock | ||
| % Loss | -22.7% | -9.5% |
| % Gain to Breakeven | 29.3% | 10.5% |
| Time to Breakeven | 7 days | 24 days |
| 2020 COVID-19 Crash | ||
| % Loss | -21.1% | -33.7% |
| % Gain to Breakeven | 26.8% | 50.9% |
| Time to Breakeven | 338 days | 140 days |
| Q4 2018 Fed Policy Error / Growth Scare | ||
| % Loss | -42.6% | -19.2% |
| % Gain to Breakeven | 74.3% | 23.8% |
| Time to Breakeven | 848 days | 105 days |
| 2015-2016 China Devaluation / Global Growth Scare | ||
| % Loss | -29.9% | -12.2% |
| % Gain to Breakeven | 42.6% | 13.9% |
| Time to Breakeven | 204 days | 62 days |
| 2014-2016 Oil Price Collapse | ||
| % Loss | -26.3% | -6.8% |
| % Gain to Breakeven | 35.6% | 7.3% |
| Time to Breakeven | 1939 days | 15 days |
In The Past
FG Nexus's stock fell -26.2% during the 2025 US Tariff Shock. Such a loss loss requires a 35.5% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About FG Nexus (FGNX)
FG Nexus (FGNX) operates as a holding company with a dual focus on reinsurance and investment management, particularly within the realm of Special Purpose Acquisition Companies (SPACs). The company, which was formerly known as 1347 Property Insurance Holdings, Inc., rebranded in December 2020 to reflect its diversified business model.
A primary component of FG Nexus's business involves offering specialty property and casualty (P&C) reinsurance products and services. In this capacity, the company provides financial protection to other insurance companies, helping them manage and mitigate risks associated with unique and specialized P&C exposures. Their main customers for this segment are insurance carriers seeking to cede specific portions of their underwriting risk.
Beyond reinsurance, FG Nexus also runs a dedicated Special Purpose Acquisition Company (SPAC) platform. Through this platform, the company provides crucial strategic, administrative, and regulatory support services to newly formed SPACs. These services assist SPACs throughout their formation and search for a target company, with FG Nexus earning a recurring monthly fee for facilitating these essential functions.
AI Analysis | Feedback
Here are 1-2 brief analogies for FG Nexus (FGNX):
- The "General Re" (part of Berkshire Hathaway) for specialty property and casualty reinsurance.
- Like a Y Combinator for SPACs, offering strategic and operational support to newly formed "blank check" companies.
AI Analysis | Feedback
- Specialty Property and Casualty Reinsurance: Provides products and services that allow other insurance companies to transfer a portion of their property and casualty risks.
- SPAC Platform Services: Offers strategic, administrative, and regulatory support to newly formed Special Purpose Acquisition Companies (SPACs) for a monthly fee.
AI Analysis | Feedback
Major Customers of FG Nexus (FGNX)
FG Nexus (FG Financial Group, Inc.) primarily sells its products and services to other companies, rather than individuals.
Based on the company description, its major customers fall into two main categories:
- Other Insurance Companies: As a provider of specialty property and casualty reinsurance products and services, FG Nexus serves other insurance companies seeking to transfer risk. Specific customer names are not disclosed in the provided information.
- Special Purpose Acquisition Companies (SPACs): The company operates a SPAC platform, providing strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. Specific customer SPAC names are not disclosed.
AI Analysis | Feedback
AI Analysis | Feedback
D. Kyle Cerminara, Chief Executive Officer
Mr. Cerminara has over 25 years of experience as an institutional investor, asset manager, director, chief executive, founder, and operator of various financial services and technology businesses. He founded Fundamental Global Investors LLC in 2012, where he serves as CEO and Partner. He assumed the role of Chairman and Chief Executive Officer of FG Nexus, Inc. in 2024. Following the merger in March 2024, he became the CEO of the combined entity, Fundamental Global Inc. Mr. Cerminara served as Director and President of FG New America Acquisition Corp., a special purpose acquisition company (SPAC) that merged with OppFi Inc. He also co-sponsored Aldel Financial Inc., another SPAC which merged with Hagerty. FG Financial Group allocates capital in partnership with Fundamental Global®, a private partnership led by Kyle Cerminara and Joe Moglia, indicating a pattern of managing companies backed by private equity-like structures he co-leads.
Mark D. Roberson, Chief Financial Officer
Mr. Roberson was appointed Chief Financial Officer on February 29, 2024. He served as the Chief Executive Officer of FG Group Holdings from April 2020 until its merger with FG Financial Group, and previously as Executive Vice President, Chief Financial Officer, and Treasurer of FG Group Holdings from November 2018 to April 2020. With over 20 years of financial and operational management experience, his background includes roles at Curtiss-Wright, Inc., Krispy Kreme Doughnut Corporation, and LifeStyle Furnishings International, which was a private equity-backed furniture manufacturer. He also serves as the CEO of Strong Global Entertainment, Inc., a subsidiary.
Larry G. Swets, Jr., Head of Merchant Banking
Mr. Swets has led the company's merchant banking business since February 2024. He served as Chief Executive Officer of FG Financial Group from November 2020 to February 2024, following an interim CEO role from June 2020 to November 2020. In 2005, Mr. Swets founded Itasca Financial LLC, an advisory and investment firm, and has been its managing member since its inception. He also founded Itasca Golf Managers, Inc. in 2018. Earlier in his career, he was an insurance company executive and advisor, holding positions such as director of investments and fixed income portfolio manager for Lumbermens Mutual Casualty Company (formerly Kemper Insurance Companies), where he also managed corporate transactions and divestitures during the company's runoff stage. Mr. Swets has held CEO roles at other companies, including Kingsway Financial Services Inc., and has been involved as CEO or director in several SPACs, such as FG New America Acquisition II Corp. and FG Merger II Corp. and III Corp.
Hassan Baqar, Lead of Merchant Banking and SPACs
Mr. Baqar, along with Larry Swets, leads Merchant Banking and SPACs as of the March 2024 merger. He was appointed Chief Financial Officer of FG Financial Group in August 2021, a position he held until February 2024. With over 20 years of experience in financial services, he has significant expertise in the reinsurance and SPAC industries. He founded and has served as managing member of Sequoia Financial LLC, a financial services and advisory firm, since 2007. His past roles include CFO at Bermuda-based reinsurer Insurance Income Strategies Ltd. Mr. Baqar has served as CFO for multiple SPACs, including FG New America Acquisition Corp., which successfully merged with OppFi, Inc., and Aldel Financial Inc. He is also CFO for FG Merger II Corp., FG Merger III Corp., and FG Imperii Acquisition Corp. This demonstrates a consistent pattern of managing and advising companies, particularly SPACs, through various growth and transactional phases.
Todd R. Major, Chief Accounting Officer
Mr. Major serves as the Chief Accounting Officer for FG Nexus. He also holds the position of Chief Financial Officer for Strong Global Entertainment, Inc.
AI Analysis | Feedback
Key Risks to FG Nexus (FGNX)
- Volatile SPAC Market and Regulatory Scrutiny: FG Nexus operates a special purpose acquisition company (SPAC) platform that provides strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee. The viability and attractiveness of the SPAC market are subject to significant investor sentiment fluctuations and increasing regulatory oversight, which could lead to a decline in the formation of new SPACs or reduced demand for associated services, thereby negatively impacting the company's revenue from this segment.
- Exposure to Catastrophic Events and Underwriting Risk: As a provider of specialty property and casualty reinsurance products and services, FG Nexus is inherently exposed to significant financial losses resulting from natural disasters, severe weather events, and other large-scale claims. Inaccurate risk assessment, insufficient premium pricing, or a series of unexpected catastrophic events could adversely affect its underwriting results and overall financial performance.
AI Analysis | Feedback
The primary clear emerging threat for FG Nexus (FGNX) stems from the significant downturn and increased regulatory scrutiny impacting the Special Purpose Acquisition Company (SPAC) market. FG Nexus operates a SPAC platform that provides strategic, administrative, and regulatory support services to newly formed SPACs for a monthly fee.
- Reduced SPAC Formation and Activity: The SPAC market has experienced a dramatic decline in new formations and overall activity following a peak period. This downturn is driven by factors such as poor post-merger performance of many de-SPACed companies, leading to a loss of investor confidence and a significant reduction in capital allocated to new SPAC ventures. Since FG Nexus's revenue from this segment is tied to newly formed SPACs, a sustained contraction in the SPAC market directly threatens its ability to generate fees.
- Increased Regulatory Scrutiny and Liability: The U.S. Securities and Exchange Commission (SEC) has actively proposed and implemented new rules aimed at increasing disclosure requirements, investor protection, and liability for participants in SPAC transactions. These regulatory changes are making SPACs less attractive as a vehicle for companies to go public, increasing the burden and complexity for sponsors and potentially further stifling the formation of new SPACs. This regulatory environment poses a direct and significant threat to the viability and profitability of FG Nexus's SPAC platform business model.
AI Analysis | Feedback
FG Nexus (FGNX) operates in two main addressable markets: specialty property and casualty reinsurance and special purpose acquisition company (SPAC) platform services.
Specialty Property and Casualty Reinsurance Market
The global property and casualty (P&C) reinsurance market demonstrates substantial size and projected growth. In 2022, the market was valued at approximately USD 427.4 billion, with projections indicating an increase to USD 718.8 billion by 2028, growing at a compound annual growth rate (CAGR) of 9.1%. Other estimates show the global reinsurance market size reaching USD 581.3 billion in 2024 and expanding to USD 1,165.7 billion by 2033, with a CAGR of 8.04% from 2025 to 2033. Further data suggests the P&C reinsurance market was approximately USD 509.34 billion in 2025, growing to USD 566.47 billion in 2026 at an 11.2% CAGR, and is expected to reach USD 889.04 billion by 2030 at an 11.9% CAGR.
Within the United States, the demand for reinsurance is significant, with the market value forecasted to reach US$ 187.5 billion by the end of 2033. The market size for reinsurance carriers in the United States exceeded US$ 109 billion in 2022. The U.S. P&C Reinsurance Providers market alone was estimated at US$78.8 billion in 2024.
Special Purpose Acquisition Company (SPAC) Platform Services Market
FG Nexus provides strategic, administrative, and regulatory support services to newly formed SPACs. The addressable market for these services can be contextualized by the overall activity and capital raised in the SPAC market.
The SPAC market experienced a boom in 2020 and 2021. In 2020, nearly 250 SPACs raised over $83 billion. The peak occurred in 2021, with 613 SPAC IPOs raising approximately $162 billion globally. Following this surge, the market saw a decrease, with 86 SPAC IPOs raising $13.4 billion in 2022. In 2023, there were 31 IPOs.
More recently, the SPAC market has shown signs of resurgence. In 2024, the SPAC IPO deal volume was USD 1.27 billion, with 57 SPAC IPOs raising $9,672 million. For the first three quarters of 2025, close to 100 SPAC IPOs on U.S. exchanges raised approximately $20,760 million in total gross proceeds. Globally, the value of SPAC IPOs totaled $18.05 billion through September 11, 2025. By the end of 2025, the total capital raised by SPACs reached $28 billion. As of the current time, 2026 has seen 56 SPAC IPOs, with gross proceeds of $12,162.1 million.
AI Analysis | Feedback
AI Analysis | Feedback
Share Repurchases
- FG Nexus's Board of Directors approved an open-ended share repurchase program in September 2025, authorizing the acquisition of up to $200 million of the company's common stock.
- The company has repurchased a significant number of common shares under its buyback programs, including 7 million shares under a mandate reported in December 2025.
- A preferred share repurchase program for its Series A preferred stock has also been authorized.
Share Issuance
- On February 29, 2024, FG Financial Group, Inc. completed an all-stock merger transaction with FG Group Holdings, Inc., where FG Group Holdings common stockholders received one share of FG Financial Group's common stock for each of their shares.
- The company has undertaken a substantial private placement of common stock and pre-funded warrants.
- A 1-for-5 reverse stock split was implemented on February 13, 2026, which reduced common shares outstanding from approximately 32.8 million to 6.55 million shares on a pro forma basis.
Inbound Investments
- FG Nexus has undertaken a substantial private placement of common stock and pre-funded warrants.
Outbound Investments
- In October 2022, FG Financial Group invested $2.0 million into FG Communities Inc.
- The company co-founded FG Merchant Partners, LP (formerly FG SPAC Partners, LP) to participate as a co-sponsor for newly formed SPACs and provide merchant banking services.
Capital Expenditures
- Capital expenditures were reported as -$171.77 million in the last 12 months.
- The company has demonstrated a 5-year annual growth in capital expenditures of 72.6%.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 4.21 |
| Mkt Cap | 0.4 |
| Rev LTM | 23 |
| Op Inc LTM | -12 |
| FCF LTM | -22 |
| FCF 3Y Avg | 34 |
| CFO LTM | -19 |
| CFO 3Y Avg | 34 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 10.3% |
| Rev Chg 3Y Avg | 30.7% |
| Rev Chg Q | -4.3% |
| QoQ Delta Rev Chg LTM | -1.1% |
| Op Inc Chg LTM | -17.9% |
| Op Inc Chg 3Y Avg | -3.3% |
| Op Mgn LTM | -20.4% |
| Op Mgn 3Y Avg | -21.0% |
| QoQ Delta Op Mgn LTM | -3.7% |
| CFO/Rev LTM | -37.7% |
| CFO/Rev 3Y Avg | -20.2% |
| FCF/Rev LTM | -38.1% |
| FCF/Rev 3Y Avg | -20.7% |
FDA Approved Drugs Data
Expand for More| Post-Approval Fwd Returns | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FDA App # | Brand Name | Generic Name | Dosage Form | FDA Approval | 3M Rtn | 6M Rtn | 1Y Rtn | 2Y Rtn | Total Rtn |
| ANDA217108 | TACROLIMUS | tacrolimus | injectable | 2122025 | -22.5% | 15.3% | -92.0% | -94.7% | -94.7% |
| ANDA217561 | METHYLENE BLUE | methylene blue | solution | 11212024 | -35.8% | -49.1% | -92.3% | -96.3% | -96.3% |
| ANDA216783 | CYCLOPHOSPHAMIDE | cyclophosphamide | solution | 10292024 | -25.8% | -44.4% | -86.7% | -96.1% | -96.1% |
| ANDA216877 | TRANEXAMIC ACID | tranexamic acid | solution | 4162024 | -30.6% | -32.1% | -55.7% | -96.4% | -96.8% |
| ANDA215709 | FLUORESCEIN SODIUM | fluorescein sodium | injectable | 9252023 | 6.9% | 7.6% | -22.9% | -81.1% | -96.5% |
| ANDA217535 | SODIUM CHLORIDE 0.9% | sodium chloride | solution | 8232023 | 0.3% | -2.0% | -26.1% | -52.1% | -96.6% |
| ANDA217704 | POTASSIUM CHLORIDE | potassium chloride | injectable | 8142023 | -2.9% | -9.3% | -36.4% | -29.8% | -96.8% |
| ANDA213947 | TIROFIBAN HYDROCHLORIDE | tirofiban hydrochloride | solution | 7242023 | -20.2% | -20.2% | -36.2% | -48.3% | -97.2% |
| ANDA217536 | STERILE WATER FOR INJECTION | sterile water for injection | liquid | 7112023 | -15.0% | -16.2% | -43.1% | -60.5% | -97.3% |
| ANDA215057 | NELARABINE | nelarabine | injectable | 6022023 | -17.7% | -26.9% | -29.7% | -62.4% | -97.4% |
| ... | |||||||||
| Post-Approval Fwd Returns | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FDA App # | Brand Name | Generic Name | Dosage Form | FDA Approval | 3M Rtn | 6M Rtn | 1Y Rtn | 2Y Rtn | Total Rtn |
| ANDA217108 | TACROLIMUS | tacrolimus | injectable | 2122025 | -22.5% | 15.3% | -92.0% | -94.7% | -94.7% |
| ANDA217561 | METHYLENE BLUE | methylene blue | solution | 11212024 | -35.8% | -49.1% | -92.3% | -96.3% | -96.3% |
| ANDA216783 | CYCLOPHOSPHAMIDE | cyclophosphamide | solution | 10292024 | -25.8% | -44.4% | -86.7% | -96.1% | -96.1% |
| ANDA216877 | TRANEXAMIC ACID | tranexamic acid | solution | 4162024 | -30.6% | -32.1% | -55.7% | -96.4% | -96.8% |
| ANDA215709 | FLUORESCEIN SODIUM | fluorescein sodium | injectable | 9252023 | 6.9% | 7.6% | -22.9% | -81.1% | -96.5% |
| ANDA217535 | SODIUM CHLORIDE 0.9% | sodium chloride | solution | 8232023 | 0.3% | -2.0% | -26.1% | -52.1% | -96.6% |
| ANDA217704 | POTASSIUM CHLORIDE | potassium chloride | injectable | 8142023 | -2.9% | -9.3% | -36.4% | -29.8% | -96.8% |
| ANDA213947 | TIROFIBAN HYDROCHLORIDE | tirofiban hydrochloride | solution | 7242023 | -20.2% | -20.2% | -36.2% | -48.3% | -97.2% |
| ANDA217536 | STERILE WATER FOR INJECTION | sterile water for injection | liquid | 7112023 | -15.0% | -16.2% | -43.1% | -60.5% | -97.3% |
| ANDA215057 | NELARABINE | nelarabine | injectable | 6022023 | -17.7% | -26.9% | -29.7% | -62.4% | -97.4% |
| ANDA215290 | ERYTHROMYCIN LACTOBIONATE | erythromycin lactobionate | injectable | 2142022 | -8.3% | -51.0% | -12.4% | -60.1% | -98.6% |
| ANDA214727 | POTASSIUM CHLORIDE 20MEQ | potassium chloride | injectable | 3182021 | 80.6% | 3.3% | -38.8% | -58.4% | -99.1% |
| ANDA213552 | SUCCINYLCHOLINE CHLORIDE | succinylcholine chloride | injectable | 10272020 | 35.5% | 157.3% | 31.2% | -30.9% | -98.5% |
| ANDA213532 | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | injectable | 7062020 | -17.0% | -26.1% | 92.6% | -67.1% | -99.0% |
| NDA213407 | EMERPHED | ephedrine sulfate | solution | 4172020 | -4.6% | -37.1% | 30.4% | -26.8% | -99.1% |
| ANDA204860 | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | injectable | 2152019 | 28.6% | 14.2% | 25.5% | 8.0% | -99.0% |
| ANDA206468 | DICYCLOMINE HYDROCHLORIDE | dicyclomine hydrochloride | injectable | 2012019 | 11.8% | 12.1% | 26.2% | -20.3% | -99.0% |
| ANDA207794 | BUSULFAN | busulfan | injectable | 1142019 | 20.7% | 15.1% | 28.1% | -18.1% | -98.9% |
| ANDA209780 | ARSENIC TRIOXIDE | arsenic trioxide | injectable | 11152018 | -14.3% | 5.5% | -12.2% | -43.0% | -99.1% |
| ANDA206332 | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | injectable | 10132017 | -4.1% | -7.5% | -13.8% | -39.1% | -99.4% |
| ANDA206961 | ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride | injectable | 8022017 | -5.5% | -8.6% | -4.7% | -32.7% | -99.4% |
| ANDA207499 | SODIUM NITROPRUSSIDE | sodium nitroprusside | injectable | 5252017 | 9.4% | -2.7% | 2.7% | -23.0% | -99.4% |
| ANDA040575 | TESTOSTERONE ENANTHATE | testosterone enanthate | injectable | 6142006 | |||||
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Digital Assets | 1 | ||||
| Merchant Banking | 1 | -15 | |||
| Other | 0 | 0 | 0 | 0 | |
| Managed Services | 32 | ||||
| Asset Management | 1 | 4 | 5 | ||
| Insurance | 26 | 16 | 2 | ||
| Total | 2 | 17 | 27 | 20 | 8 |
| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Digital Assets | 119 | ||||
| Other | 30 | 38 | 3 | 3 | 15 |
| Merchant Banking | 15 | 60 | |||
| Managed Services | 11 | ||||
| Asset Management | 18 | 19 | 11 | ||
| Insurance | 45 | 27 | 15 | ||
| Total | 164 | 109 | 66 | 49 | 41 |
Price Behavior
| Market Price | $5.67 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 04/01/2014 | |
| Distance from 52W High | -97.0% | |
| 50 Days | 200 Days | |
| DMA Price | $45.34 | $68.50 |
| DMA Trend | down | up |
| Distance from DMA | -87.5% | -91.7% |
| 3M | 1YR | |
| Volatility | 105.2% | 157.8% |
| Downside Capture | 654.82 | 369.46 |
| Upside Capture | 294.50 | -49.24 |
| Correlation (SPY) | 63.8% | 17.3% |
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 6.05 | 6.66 | 4.47 | 4.26 | 2.01 | 0.63 |
| Up Beta | 3.35 | 9.14 | 4.53 | 5.49 | 4.37 | 0.47 |
| Down Beta | 5.94 | 3.13 | 2.99 | 3.79 | 1.61 | 0.65 |
| Up Capture | 756% | 638% | 715% | 383% | -23% | -0% |
| Bmk +ve Days | 13 | 28 | 36 | 67 | 141 | 432 |
| Stock +ve Days | 10 | 21 | 28 | 49 | 99 | 315 |
| Down Capture | 741% | 600% | 381% | 298% | 192% | 109% |
| Bmk -ve Days | 7 | 13 | 27 | 57 | 109 | 318 |
| Stock -ve Days | 10 | 19 | 34 | 72 | 138 | 388 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGNX | |
|---|---|---|---|---|
| FGNX | -93.2% | 158.3% | -1.03 | - |
| Sector ETF (XLF) | 8.3% | 14.6% | 0.33 | 11.2% |
| Equity (SPY) | 26.5% | 12.4% | 1.61 | 17.7% |
| Gold (GLD) | 24.2% | 27.5% | 0.77 | 11.7% |
| Commodities (DBC) | 19.8% | 18.8% | 0.83 | -9.6% |
| Real Estate (VNQ) | 11.0% | 13.7% | 0.52 | 13.9% |
| Bitcoin (BTCUSD) | -40.0% | 42.5% | -1.08 | 26.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGNX | |
|---|---|---|---|---|
| FGNX | -61.9% | 105.0% | -0.49 | - |
| Sector ETF (XLF) | 9.3% | 18.6% | 0.37 | 12.8% |
| Equity (SPY) | 13.5% | 17.1% | 0.62 | 11.8% |
| Gold (GLD) | 17.1% | 18.3% | 0.76 | 7.4% |
| Commodities (DBC) | 7.5% | 19.4% | 0.29 | 0.8% |
| Real Estate (VNQ) | 1.9% | 18.9% | 0.00 | 11.7% |
| Bitcoin (BTCUSD) | 11.0% | 54.2% | 0.40 | 12.0% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with FGNX | |
|---|---|---|---|---|
| FGNX | -37.0% | 83.9% | -0.19 | - |
| Sector ETF (XLF) | 13.0% | 22.2% | 0.54 | 10.2% |
| Equity (SPY) | 15.3% | 18.0% | 0.73 | 10.6% |
| Gold (GLD) | 12.3% | 16.1% | 0.63 | 4.9% |
| Commodities (DBC) | 5.9% | 18.0% | 0.26 | 3.0% |
| Real Estate (VNQ) | 5.3% | 20.7% | 0.22 | 9.7% |
| Bitcoin (BTCUSD) | 60.0% | 66.8% | 1.00 | 6.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Updated 6/9/2026| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/21/2025 | -0.4% | 26.6% | 26.1% |
| 4/2/2025 | 2.7% | -0.8% | -4.7% |
| 11/14/2024 | 15.9% | 15.9% | -7.9% |
| 8/14/2024 | -2.4% | -3.9% | -5.1% |
| 6/20/2024 | 0.0% | -8.6% | -7.1% |
| 3/14/2024 | 5.8% | -2.2% | 5.8% |
| 11/13/2023 | 4.4% | 2.9% | -1.5% |
| 8/10/2023 | 3.9% | -15.8% | -11.2% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 8 | 8 |
| # Negative | 9 | 12 | 12 |
| Median Positive | 4.4% | 18.3% | 18.0% |
| Median Negative | -2.5% | -6.4% | -6.1% |
| Max Positive | 15.9% | 34.4% | 26.1% |
| Max Negative | -15.4% | -21.1% | -45.1% |
| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/21/2025 | -0.4% | 26.6% | 26.1% |
| 4/2/2025 | 2.7% | -0.8% | -4.7% |
| 11/14/2024 | 15.9% | 15.9% | -7.9% |
| 8/14/2024 | -2.4% | -3.9% | -5.1% |
| 6/20/2024 | 0.0% | -8.6% | -7.1% |
| 3/14/2024 | 5.8% | -2.2% | 5.8% |
| 11/13/2023 | 4.4% | 2.9% | -1.5% |
| 8/10/2023 | 3.9% | -15.8% | -11.2% |
| 5/30/2023 | -15.4% | -21.1% | -24.6% |
| 3/24/2023 | 9.3% | 21.9% | 12.6% |
| 11/9/2022 | 14.2% | 11.9% | 18.8% |
| 8/11/2022 | -2.5% | -0.6% | 4.4% |
| 5/16/2022 | -1.0% | -7.6% | -45.1% |
| 3/30/2022 | -1.4% | 34.4% | 17.2% |
| 11/15/2021 | -5.9% | -15.2% | -17.8% |
| 8/16/2021 | -10.4% | -17.4% | -3.0% |
| 5/14/2021 | 7.2% | 20.7% | 19.4% |
| 3/18/2021 | 2.3% | 0.0% | 24.5% |
| 11/16/2020 | -3.5% | -3.9% | -4.5% |
| 8/14/2020 | 0.0% | -5.2% | -2.0% |
| SUMMARY STATS | |||
| # Positive | 11 | 8 | 8 |
| # Negative | 9 | 12 | 12 |
| Median Positive | 4.4% | 18.3% | 18.0% |
| Median Negative | -2.5% | -6.4% | -6.1% |
| Max Positive | 15.9% | 34.4% | 26.1% |
| Max Negative | -15.4% | -21.1% | -45.1% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/07/2026 | 10-Q |
| 12/31/2025 | 03/27/2026 | 10-K |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/14/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/20/2024 | 10-Q |
| 12/31/2023 | 03/14/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-Q |
| 03/31/2023 | 05/12/2023 | 10-Q |
| 12/31/2022 | 03/24/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| 06/30/2022 | 08/11/2022 | 10-Q |
| Report Date | Filing Date | Filing |
|---|---|---|
| 03/31/2026 | 05/07/2026 | 10-Q |
| 12/31/2025 | 03/27/2026 | 10-K |
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/14/2025 | 10-Q |
| 12/31/2024 | 03/31/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/20/2024 | 10-Q |
| 12/31/2023 | 03/14/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-Q |
| 03/31/2023 | 05/12/2023 | 10-Q |
| 12/31/2022 | 03/24/2023 | 10-K |
| 09/30/2022 | 11/09/2022 | 10-Q |
| 06/30/2022 | 08/11/2022 | 10-Q |
| 03/31/2022 | 05/16/2022 | 10-Q |
| 12/31/2021 | 03/30/2022 | 10-K |
| 09/30/2021 | 11/15/2021 | 10-Q |
| 06/30/2021 | 08/16/2021 | 10-Q |
| 03/31/2021 | 05/14/2021 | 10-Q |
| 12/31/2020 | 03/18/2021 | 10-K |
| 09/30/2020 | 11/16/2020 | 10-Q |
| 06/30/2020 | 08/14/2020 | 10-Q |
| 03/31/2020 | 05/14/2020 | 10-Q |
| 12/31/2019 | 03/30/2020 | 10-K |
| 09/30/2019 | 11/14/2019 | 10-Q |
| 06/30/2019 | 08/14/2019 | 10-Q |
Insider Activity
Updated 4/26/2026| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mitchell, Michael C | Direct | Buy | 5212025 | 16.45 | 10,000 | 164,450 | 214,837 | Form |
| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mitchell, Michael C | Direct | Buy | 5212025 | 16.45 | 10,000 | 164,450 | 214,837 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Asset Management & Custody Banks Resources |
| Pensions & Investments |
| Institutional Investor |
| Ignites |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.